Sustained activation of EGFR-ERK1/2 signaling limits the therapeutic response to tigecycline-induced inhibition of mitochondrial translation in liver cancer

Wenxin Qin(Renji Hospital), Haojie Jin(Zhejiang University of Technology)
Research Square
March 25, 2022
Cited by 0


Related Papers